Clinical Trials Browser

Phase 2 × Recurrent Uterine Corpus Sarcoma × ixabepilone × Clear all

NCT01168232 2019-08-08

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

42 enrolled 10 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma